Evaluation of Reporting of Antibody-Drug Conjugate Associated Sepsis-related Toxicities
Condition(s):Sepsis (SMQ); Opportunistic Infections; AgranulocytosisLast Updated:June 22, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Sepsis (SMQ); Opportunistic Infections; AgranulocytosisLast Updated:June 22, 2022Completed
Condition(s):Advanced Malignant Solid Neoplasm; Metastatic Malignant Solid NeoplasmLast Updated:March 15, 2024Not yet recruiting
Condition(s):Breast CancerLast Updated:June 27, 2023Active, not recruiting
Condition(s):Prostate CancerLast Updated:November 1, 2013Completed
Condition(s):Prostate CancerLast Updated:November 14, 2013Completed
Condition(s):Breast CancerLast Updated:February 26, 2024Active, not recruiting
Condition(s):Carcinoma; Solid TumorLast Updated:November 10, 2021Not yet recruiting
Condition(s):Breast TumorsLast Updated:December 7, 2023Active, not recruiting
Condition(s):Relapsed Solid Neoplasm; Refractory Cancer; Solid Tumor, AdultLast Updated:January 26, 2023Withdrawn
Condition(s):Solid TumorLast Updated:November 1, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.